Abstract
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) is currently approved in Japan for treatment of breast cancer. However, apart from phase I clinical trials, data regarding Japanese patients are scant. In the present study, the efficacy and safety of nab-paclitaxel therapy were retrospectively analyzed in 22 patients with advanced or metastatic breast cancer who were treated at the National Hospital Organization Shikoku Cancer Center between November 2010 and June 2012. The nab-paclitaxel was administered once every three weeks. The median age of the patients was 59 years. The tumors were estrogen-receptor positive and/or progesterone-receptor positive in 63.6% patients. None of the patients had HER2-positive breast cancer. The median number of treatment cycles was six (range, two to 12). Six patients exhibited a partial response; the response rate was 27.3% and the clinical benefit rate was 31.8%. The response rate and clinical benefit rate were higher in patients who received nab-paclitaxel as first- or second-line treatment. The median time to treatment failure was 127 days (range, 27-257). Major adverse events were peripheral neuropathy (59%; Grade 3, 9%), myalgia (59%), rash (45%), and nausea and vomiting (50%). The r...Continue Reading
References
Jul 11, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R B WeissB Leyland-Jones
Apr 13, 1995·The New England Journal of Medicine·E K Rowinsky, R C Donehower
Jun 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M NabholtzB Winograd
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K GelmonJ Iglesias
May 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Swan Swan LeongPeng Tiam Ang
Jul 11, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D LorussoUNKNOWN Multicenter Italian Trials in Ovarian Cancer invesitgators
Jan 12, 2005·Neurology·A A ArgyriouH P Kalofonos
Mar 26, 2005·Gynecologic Oncology·F Y F L De VosP H B Willemse
Jul 19, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·F HilpertUNKNOWN Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S E JonesP M Ravdin
Sep 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William J GradisharJoyce O'Shaughnessy
Nov 19, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stephan MielkeKlaus Mross
Nov 30, 2006·Breast Cancer Research : BCR·Lyndsay N HarrisLynn Dressler
Apr 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew D SeidmanClifford Hudis
Aug 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathy S AlbainJoyce O'Shaughnessy
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Citations
Jul 8, 2015·The Lancet Oncology·Giuseppe SchepisiUgo De Giorgi
Jun 12, 2016·Basic & Clinical Pharmacology & Toxicology·Xuechi LinFang Shen
Jan 8, 2016·Allergy, Asthma & Immunology Research·Young Nam KimByung Jae Lee
Jan 4, 2017·Expert Opinion on Drug Delivery·Raul C MaranhãoSilvia R Graziani
Apr 26, 2017·Oncology Reports·Yumeng WeiLing Zhao
Nov 2, 2016·Nanoscale·Zhiqiang LinQiang Zhang
Mar 6, 2017·Oncology Reports·Fang ShenXuechi Lin
Nov 28, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Yuko KanbayashiTetsuya Taguchi
Oct 31, 2020·Medicine·Stefano D'ErricoVittorio Fineschi
Mar 20, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Maria Luisa CaballeroCosby A Stone
Apr 8, 2020·Skin Appendage Disorders·Athina Fonia, Bertrand Richert